Related Experiment Videos
Severe postpartum pulmonary, cardiac, and renal syndrome associated with antiphospholipid antibodies
M J Kupferminc1, M J Lee, D Green
1Department of Obstetrics and Gynecology, Northwestern University Medical School, Chicago, Illinois.
Insights
Antiphospholipid antibody syndrome can cause severe postpartum multi-system issues. Prompt treatment with steroids or plasmapheresis may improve outcomes in affected women.
Area of Science:
- Obstetrics and Gynecology
- Rheumatology
- Hematology
Background:
- Antiphospholipid antibody syndrome (APS) is linked to serious pregnancy complications like severe preeclampsia and fetal growth issues.
- APS is characterized by antibodies that increase blood clot risk, affecting various organ systems.
Observation:
- A postpartum woman presented with fever, pulmonary infiltrates, cardiac conduction defects, and renal insufficiency after severe preeclampsia.
- Her serological tests confirmed the presence of lupus anticoagulant and anticardiolipin antibodies.
Findings:
- The patient demonstrated a positive response to treatment with corticosteroids and plasmapheresis.
- This case highlights the potential for diverse postpartum clinical manifestations in APS.
Implications:
- Early recognition and intervention are crucial for managing postpartum APS complications.
- Plasmapheresis and corticosteroid therapy represent viable treatment options for severe postpartum APS presentations.
Background:
The antiphospholipid antibody syndrome has been associated with thromboembolic events, thrombocytopenia, fetal death, fetal growth retardation, and early-onset severe preeclampsia.
Case:
A postpartum woman developed fever, pulmonary infiltrates, cardiac conduction defects, and renal insufficiency following severe preeclampsia. She tested positive for lupus anticoagulant and anticardiolipin antibody, and responded to steroid therapy and plasmapheresis.
Conclusion:
The postpartum multi-system involvement suggests that a variety of clinical presentations may be associated with antiphospholipid antibodies. Treatment with plasmapheresis or corticosteroids may be of value in similar cases.